does semaglutide help you stop drinking alcohol cuts cravings but not daily drinks in Phase II trial Semaglutide and Tirzepatide reduce alcohol

Available long-term data: Limited data beyond 12 weeks of continuous use No long-term safety concerns identified in available data Both peptides are based on naturally occurring compounds Theoretical profile favorable for extended use Long-term recommendations: Consider cycling on and off for very extended use Enhanced monitoring for protocols beyond 12 weeks Periodic assessment of continued need Documentation of long-term outcomes Theoretical long-term concerns: No major concerns identified Both peptides work with natural healing processes No evidence of tolerance or dependence No withdrawal effects on discontinuation Comparison to Alternative Treatments The safety profile compares favorably to alternatives

The phase II clinical study, Calcium Up-regulation by Percutaneous Administration of Gene Therapy in Cardiac Disease (CUPID2), yielded no significant therapeutic effects

The status quo has not served them

PMID: 31373028 14 Systemic primary carnitine deficiency induces severe arrhythmia due to shortening of QT interval